KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Cash & Current Investments (2016 - 2025)

Boston Scientific (BSX) has disclosed Cash & Current Investments for 17 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 374.64% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 374.64% year-over-year, with the annual reading at $2.0 billion for FY2025, 374.64% up from the prior year.
  • Cash & Current Investments hit $2.0 billion in Q4 2025 for Boston Scientific, up from $1.3 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $2.9 billion in Q2 2024 to a low of $276.0 million in Q2 2022.
  • Historically, Cash & Current Investments has averaged $1.3 billion across 5 years, with a median of $940.0 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: plummeted 89.68% in 2022 and later soared 583.8% in 2024.
  • Year by year, Cash & Current Investments stood at $1.9 billion in 2021, then tumbled by 51.79% to $928.0 million in 2022, then dropped by 6.79% to $865.0 million in 2023, then crashed by 52.14% to $414.0 million in 2024, then soared by 374.64% to $2.0 billion in 2025.
  • Business Quant data shows Cash & Current Investments for BSX at $2.0 billion in Q4 2025, $1.3 billion in Q3 2025, and $534.0 million in Q2 2025.